Jefferson Foote

Title: Jefferson Foote: Innovator in Antibody Technology

Introduction

Jefferson Foote is a notable inventor based in Seattle, WA, with a focus on advancements in antibody technology. He holds a total of 4 patents that contribute significantly to the field of biomedicine. His work emphasizes the development of methods and compositions that enhance drug efficacy through innovative antibody applications.

Latest Patents

Among his latest patents, one titled "Antibody buffering of a ligand in vivo" presents compositions and methods aimed at maintaining desired drug concentration ranges within a subject. This invention is based on the discovery that antibodies can persist in body compartments, allowing for the application of antibody-antigen equilibrium principles to counteract drug clearance mechanisms. Another significant patent, "Super humanized antibodies," outlines methods for humanizing antibodies by selecting variable region framework sequences from human antibody genes. This process involves comparing canonical CDR structure types to create high-affinity, low-immunogenicity chimeric antibodies.

Career Highlights

Jefferson Foote has made substantial contributions to the biotechnology sector through his work with various companies. He has been associated with Arrowsmith Technologies Corporation and Arrowsmith Technology Licensing LLC, where he has played a pivotal role in advancing antibody technologies.

Collaborations

Throughout his career, Jefferson has collaborated with notable professionals, including Carol E O'Hear, enhancing the impact of his innovations in the field.

Conclusion

Jefferson Foote's contributions to antibody technology through his patents and collaborations highlight his role as a significant innovator in the biomedical field. His work continues to influence the development of effective therapeutic strategies.